GETINGE Net Income 2016-2025 | GNGBY

GETINGE annual/quarterly net income history and growth rate from 2016 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • GETINGE net income for the quarter ending September 30, 2025 was $0.059B, a 30882.81% increase year-over-year.
  • GETINGE net income for the twelve months ending September 30, 2025 was $0.203B, a 25.51% increase year-over-year.
  • GETINGE annual net income for 2025 was $0.231B, a 48.93% increase from 2024.
  • GETINGE annual net income for 2024 was $0.155B, a 31.87% decline from 2023.
  • GETINGE annual net income for 2023 was $0.227B, a 7.86% decline from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
GETINGE Annual Net Income
(Millions of US $)
2025 $231
2024 $155
2023 $227
2022 $247
2021 $346
2020 $353
2019 $129
2018 $-111
2017 $161
2016 $139
2015 $165
GETINGE Quarterly Net Income
(Millions of US $)
2025-09-30 $59
2025-06-30 $54
2025-03-31 $28
2024-12-31 $61
2024-09-30 $0
2024-06-30 $49
2024-03-31 $44
2023-12-31 $68
2023-09-30 $83
2023-06-30 $20
2023-03-31 $56
2022-12-31 $53
2022-09-30 $76
2022-06-30 $61
2022-03-31 $57
2021-12-31 $87
2021-09-30 $88
2021-06-30 $95
2021-03-31 $77
2020-12-31 $118
2020-09-30 $156
2020-06-30 $51
2020-03-31 $28
2019-12-31 $96
2019-09-30 $22
2019-06-30 $11
2019-03-31 $1
2018-12-31 $80
2018-09-30 $-163
2018-06-30 $9
2018-03-31 $-38
2017-12-31 $124
2017-09-30 $6
2017-06-30 $0
2017-03-31 $31
2016-12-31 $109
2016-09-30 $-10
2016-06-30 $27
2016-03-31 $13
2015-12-31 $113
Sector Industry Market Cap Revenue
Medical Medical Services $5.626B $3.574B
Getinge AB develops, manufactures and sells products and services for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care for life science companies and institutions. The company's operating segments consists of Medical Systems, Extended Care and Infection Control. It operates primarily in the United Kingdom, France, the United States and Australia. Getinge AB is headquartered in Gothenburg, Sweden.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $134.187B 24.31
HCA Healthcare (HCA) United States $110.772B 17.53
CVS Health (CVS) United States $101.670B 11.75
Elevance Health (ELV) United States $68.432B 10.33
Cencora (COR) United States $62.409B 19.63
Natera (NTRA) United States $27.358B 0.00
Labcorp Holdings (LH) United States $21.501B 15.87
DiDi Global (DIDIY) China $18.026B 15.96
Viatris (VTRS) United States $15.685B 5.71
EUROFINS SCIENT (ERFSF) Luxembourg $14.535B 0.00
Medpace Holdings (MEDP) United States $14.094B 32.26
BioMerieux (BMXMF) France $12.476B 0.00
Solventum (SOLV) United States $11.408B 10.78
Revvity (RVTY) United States $10.039B 17.71
BrightSpring Health Services (BTSG) United States $8.774B 43.59
Charles River Laboratories (CRL) United States $8.667B 17.09
ICON (ICLR) Ireland $8.626B 8.56
CochLear (CHEOY) Australia $8.030B 0.00
Sonic Healthcare (SKHHY) Australia $6.905B 0.00
HealthEquity (HQY) United States $6.586B 23.20
Bausch + Lomb (BLCO) Canada $5.877B 32.98
Avantor (AVTR) United States $5.388B 8.68
PACS (PACS) United States $5.304B 27.44
Caris Life Sciences,�Inc (CAI) United States $5.101B 0.00
Sotera Health (SHC) United States $4.380B 19.95
Alignment Healthcare (ALHC) United States $4.188B 0.00
Concentras Parent (CON) United States $2.818B 16.12
Organon (OGN) United States $2.299B 2.57
Amplifon S.p.A (AMFPF) Italy $2.275B 13.27
Pediatrix Medical (MD) United States $1.782B 11.11
Establishment Labs Holdings (ESTA) United States $1.765B 0.00
GeneDx Holdings (WGS) United States $1.746B 42.28
Surgery Partners (SGRY) United States $1.671B 41.65
Sonida Senior Living (SNDA) United States $1.544B 0.00
Ardent Health (ARDT) United States $1.345B 5.70
Progyny (PGNY) United States $1.277B 25.08
Ryman Healthcare (RYHTY) New Zealand $1.240B 0.00
InnovAge Holding (INNV) United States $1.113B 164.00
Teladoc Health (TDOC) United States $0.920B 0.00
CareDx (CDNA) United States $0.822B 0.00
GoodRx Holdings (GDRX) United States $0.750B 12.17
Enhabit (EHAB) United States $0.709B 25.89
Nutex Health (NUTX) United States $0.704B 11.25
Omada Health (OMDA) United States $0.672B 0.00
QDM (QDMI) Hong Kong, SAR China $0.604B 99.85
COMPASS Pathways (CMPS) United Kingdom $0.531B 0.00
Embecta (EMBC) United States $0.524B 2.92
Charming Medical (MCTA) Hong Kong, SAR China $0.497B 0.00
CryoPort (CYRX) United States $0.482B 0.00
Auna S.A (AUNA) Luxembourg $0.435B 4.70
SBC Medicals (SBC) United States $0.426B 8.47
Forward Industries (FWDI) United States $0.375B 0.00
Strata Critical Medical (SRTA) United States $0.349B 0.00
Agilon Health (AGL) United States $0.316B 0.00
Shoulder Innovations (SI) United States $0.309B 0.00
Oncology Institute (TOI) United States $0.304B 0.00
So-Young (SY) China $0.262B 0.00
LifeMD (LFMD) United States $0.166B 0.00
Biodesix (BDSX) United States $0.133B 0.00
Beauty Health (SKIN) United States $0.115B 0.00
Ascend Wellness Holdings (AAWH) United States $0.091B 0.00
Park Dental Partners (PARK) United States $0.080B 0.00
Sera Prognostics (SERA) United States $0.077B 0.00
DocGo (DCGO) United States $0.051B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
Pomdoctor - (POM) China $0.031B 0.00
IceCure Medical (ICCM) Israel $0.026B 0.00
OSR Holdings (OSRH) United States $0.018B 0.00
SeaStar Medical Holding (ICU) United States $0.015B 0.00
Basel Medical Group (BMGL) Singapore $0.011B 0.00
Lifeward (LFWD) United States $0.010B 0.00
XWELL (XWEL) United States $0.009B 0.00
Aclarion (ACON) United States $0.007B 0.00
Synergy CHC (SNYR) United States $0.007B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Co-Diagnostics (CODX) United States $0.005B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00